Press release
Forecasting the Global Drug Delivery Devices Market Growth at 7.90% CAGR till 2028, DelveInsight Report | Pfizer, Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd, Novartis AG, 3M Bayer AG, uniQure N.V., Shenzhen (SiBiono) GeneTech Co.
As per DelveInsight's assessment, the Drug Delivery Devices Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Drug Delivery Devices have been used, which is expected to drive the demand for Drug Delivery Devices in the upcoming years.DelveInsight's "Drug Delivery Devices Market" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Drug Delivery Devices companies actively working in the market.
Drug Delivery Devices Overview
https://www.delveinsight.com/sample-request/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Drug delivery devices are specialized instruments used to administer a medicinal substance or medicine through a particular route. These gadgets are a component of one or more medical interventions.
Drug Delivery Devices Market Insights
The market for drug delivery devices is expected to grow overall between 2023 and 2028 due to factors such as the rising incidence of diabetes, cancer, and other diseases, as well as technological advancements in the field of drug delivery devices and the growing geriatric population, which increases the risk of developing chronic illnesses.
DelveInsight Analysis: The Global Drug Delivery Devices market size is anticipated to reach ~USD 162 billion by 2028 with a growing CAGR of 7.90% during the forecasted period (2023-2028).
To know more about why North America is leading the market growth in the Drug Delivery Devices market, get a snapshot of the report Drug Delivery Devices Market Trends
https://www.delveinsight.com/report-store/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Drug Delivery Devices Market Report
• On December 08, 2020, AireHealth had earned the Food and Drug Administration 510(k) clearance for portable nebulizers.
• On April 13, 2020, B Braun had received the Food and Drug Emergency Use Authorization for using infusion pumps with nebulizers for treatment of COVID-19 patients.
• On September 10, 2020, Food and Drug Administration had approved GSK's three-drug asthma inhaler.
• On April 08, 2020, FDA had approved the first generic albuterol inhaler.
• On October 15, 2019, U.S. FDA had approved the Transdermal System, the first and only transdermal patch
To read more about the latest highlights related to Drug Delivery Devices, get a snapshot of the key highlights entailed in the Drug Delivery Devices Market Forecast Report
https://www.delveinsight.com/sample-request/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Key Players in the Drug Delivery Devices Market
Some of the key market players operating in the Drug Delivery Devices market include- Pfizer, Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd, Novartis AG, 3M Bayer AG, uniQure N.V., Shenzhen (SiBiono) GeneTech Co. Ltd (Hubei Tongji Benda Ebei Pharmaceuticals), Antares Pharma, Inc, GlaxoSmithKline plc, AstraZeneca PLC, Becton Dickinson, Boehringer Ingelheim group, Consort Medical plc (Recipharm Group), Insulet Corporation, Medtronic Plc, Sulzer Ltd., West Pharmaceuticals Services, Inc, Generx Biotechnology, Panacea Pharmaceuticals Inc., Aptar Pharma, Koninklijke Philips N.V., Nemera, Biocorp Production., and Eli Lilly and Co. and others.
COVID-19 Impact Analysis on the Drug Delivery Devices Market
According to estimates, the market for medication delivery devices is dominated by North America. The importance of important growth factors like the prevalence of chronic illnesses throughout the region, the rise in research and development as a result of these conditions, the rising use of biologics, the rise in the use of medication delivery systems in home-care settings, the growing number of drug delivery device approvals in the North American region, and the government's increased emphasis on facilitating access to healthcare services have all contributed to the growth of this market.
Additionally, The drug delivery devices market has been affected positively after the emergence of the COVID-19 infections. Despite the unanticipated and catastrophic effects of the COVID-19 pandemic, the demand for drug delivery devices was positively impacted by the pandemic due to an increase in immunization rates and a rise in COVID-19 cases as a result of the pandemic's second wave. The demand for drug delivery devices, which are used to administer vaccination medications, has increased further due to the rapidly rising number of COVID-19 cases and the mounting pressure on the government to increase the number of vaccinations in order to get the population inoculated against COVID-19. So, during the projected period, the market for Drug Delivery Devices is anticipated to continue expanding (2023-2028).
Scope of the Drug Delivery Devices Market Report
• Coverage: Global
• Study Period: 2020-2028
• Drug Delivery Devices Market Segmentation By Type: Monoclonal Antibodies, Immunomodulators, Cancer Vaccines, Checkpoint Inhibitors, And Others
• Drug Delivery Devices Market Segmentation By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others
• Drug Delivery Devices Market Segmentation By End User: Hospitals And Clinics, Specialty Centers, And Others
• Drug Delivery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Drug Delivery Devices Companies: Pfizer, Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd, Novartis AG, 3M Bayer AG, uniQure N.V., Shenzhen (SiBiono) GeneTech Co. Ltd (Hubei Tongji Benda Ebei Pharmaceuticals), Antares Pharma, Inc, GlaxoSmithKline plc, AstraZeneca PLC, Becton Dickinson, Boehringer Ingelheim group, Consort Medical plc (Recipharm Group), Insulet Corporation, Medtronic Plc, Sulzer Ltd., West Pharmaceuticals Services, Inc, Generx Biotechnology, Panacea Pharmaceuticals Inc., Aptar Pharma, Koninklijke Philips N.V., Nemera, Biocorp Production., and Eli Lilly and Co. and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the Drug Delivery Devices market are set to emerge as the trendsetter explore @ Drug Delivery Devices Manufacturer
https://www.delveinsight.com/sample-request/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Drug Delivery Devices Market Report Introduction
2 Drug Delivery Devices Market Executive summary
3 Regulatory and Patent Analysis
4 Drug Delivery Devices Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Drug Delivery Devices Market
7 Drug Delivery Devices Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Drug Delivery Devices Market Drivers
11. Drug Delivery Devices Market Barriers
12. Project Approach
13. About DelveInsight
Interested in knowing how the Drug Delivery Devices market will grow by 2028? Click to get a snapshot of the Drug Delivery Devices Market Analysis
https://www.delveinsight.com/sample-request/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Latest Reports Offered By DelveInsight:
Oncology Drugs Market
https://www.delveinsight.com/report-store/oncology-drugs-market
Oncology Drugs Market By Therapy Type (Chemotherapy, Hormonal Therapy, Targeted Therapy [Gene Therapy And Immunotherapy], And Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancers, And Others), By End User (Hospitals, Specialty Clinics, And Others), and by geography is estimated to grow at a healthy CAGR forecast till 2028 due to rising prevalence of various cancers such as lung and breast cancers and growing demand for targeted therapies for cancer treatment.
Biologics Market
https://www.delveinsight.com/report-store/biologics-market
Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseases, And Others), By Manufacturing Type (In-House And Outsourced), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to rising prevalence of autoimmune disorders such as rheumatoid arthiritis and genetic disorders.
Biosimilar Market
https://www.delveinsight.com/report-store/biosimilars-market
Biosimilars Market By Product Class (Monoclonal Antibodies, Recombinant Hormone/Proteins, Anti-Inflammatory Agents, Immunomodulators, And Others), By Manufacturing Type (In-House And Outsourced/Contract), By Application (Autoimmune Diseases, Blood Disorders, Oncology, Infectious Diseases, And Others), by geography, is projected to expand at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders such as autoimmune disorders, cancers, among others and increasing demand for biosimilar drugs owing to their cost-effectiveness.
Cancer Immunotherapy Market
https://www.delveinsight.com/report-store/cancer-immunotherapy-market
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines, Checkpoint Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By End-User (Hospitals And Clinics, Specialty Centers, And Others), and by geography is expected to rise at a significant CAGR forecast till 2027 owing to the accelerating prevalence of cancers and surging healthcare expenditure across the globe
Companion Diagnostics Market
https://www.delveinsight.com/report-store/companion-diagnostics-market
Companion Diagnostics Market By Type (Product [Assays, Kits & Reagents And Instruments], and Services), Technology (Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, and Others), End-User (Hospitals, Diagnostic Labs, and Others), and Geography is expected to grow at a noteworthy CAGR till 2028 owing to the increase in the cancer burden across the globe and the growing focus on personalized medicines.
Contact Us
Gaurav Bora
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/medical-devices
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Forecasting the Global Drug Delivery Devices Market Growth at 7.90% CAGR till 2028, DelveInsight Report | Pfizer, Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd, Novartis AG, 3M Bayer AG, uniQure N.V., Shenzhen (SiBiono) GeneTech Co. here
News-ID: 3302802 • Views: …
More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…

Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…

Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…

Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…